Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approvals
Pharma
Autolus enters CAR-T race with FDA approval for Aucatzyl
Autolus is ready to hit the ground running with an FDA nod for its CD19 CAR-T Aucatzyl, a competitor to Gilead's Tecartus and Novartis' Kymriah.
Zoey Becker
Nov 11, 2024 11:30am
Novartis' Scemblix leaps into newly diagnosed CML
Oct 29, 2024 3:56pm
FDA approves Protega's 10 mg abuse-deterrent opioid Roxybond
Oct 29, 2024 11:47am
Astellas, Otsuka, Samsung Biologics—Fierce Pharma Asia
Oct 25, 2024 8:43am
Roche burnishes breast cancer portfolio with FDA nod for Itovebi
Oct 10, 2024 5:30pm
BMS wins FDA approval for new schizophrenia med Cobenfy
Sep 26, 2024 7:38pm
